FIELD: pharmacology.
SUBSTANCE: drug containing glycine and thiotriazoline is presented.
EFFECT: high primary neuroprotective activity due to mutually reinforcing action, which are part of the preparations, and a wide range of biological effects.
3 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED DRUG FOR PHARMACORRECTION OF COGNITIVE DYSFUNCTIONS AFTER KETAMINE ANESTHESIA | 2020 |
|
RU2748035C1 |
| COMBINED DRUG OF ANXIOLITHIC, STRESS-PROTECTOR, NOOTROPIC AND ANTIOXIDANT ACTION | 2016 |
|
RU2625754C1 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| CEREBROPROTECTIVE AND NOOTROPIC MEDICINAL AGENT "NOOTRIL" IN ENVELOPE-COVERED TABLET | 2003 |
|
RU2248203C2 |
| COMBINATION IN ORAL DISPERSIBLE FORM WITH THERAPEUTIC ACTION ON ACTIVATING AND INHIBITORY FUNCTIONS OF NERVOUS SYSTEM (VERSIONS) | 2011 |
|
RU2464013C1 |
| PHARMACEUTICAL COMBINATION INFLUENCING CENTRAL NERVOUS SYSTEM FUNCTION; METHOD OF CORRECTING CONDITIONS ASSOCIATED WITH DYSFUNCTION OF CENTRAL NERVOUS SYSTEM; PHARMACEUTICAL KIT; AGENT ASSISTING THERAPEUTICAL SUBSTANCES AND METABOLITES TO CROSS BLOOD-BRAIN BARRIER; AND ENDONASAL DRUG | 2004 |
|
RU2253461C1 |
| COMPOSITIONS OF PROTECTORS AGAINST ACUTE AND CHRONIC HEPATIC ENCEPHALOPATHIES AND METHOD OF TREATING ACUTE AND CHRONIC HEPATIC ENCEPHALOPATHIES | 2011 |
|
RU2491062C2 |
| ANTICONVULSANT MEDICAL PRODUCT | 2007 |
|
RU2361591C1 |
| BIOLOGIALLY ACTIVE AGENT HAVING EFFECT ON GENERAL METABOLIC, EXCITATORY AND INHIBITORY NERVE FUNCTION AND INTELLECTUAL MNESTIC CEREBRAL FUNCTIONS (VERSIONS) | 2011 |
|
RU2461374C1 |
